Refine by
Oxygen Diffuser Articles & Analysis
33 news found
Europelec Strengthens Partnership with SUEZ by Supplying 1,252 AQUADISC 320 Diffusers for the Grande-Synthe Wastewater Treatment Plant (WWTP). As part of its operating contract, SUEZ is committed to ensuring the performance and compliance of aeration equipment. Replacing the fine-bubble disc air diffusers, essential for optimal oxygenation and ...
As part of the modernization of a wastewater treatment plant (WWTP) in Ille-et-Vilaine, EUROPELEC was selected to replace the fine bubble air diffusers in the aeration basin, which had reached the end of their service life. ...
Diffusion in Active Bidding Stage and Encouraged by Response to the Strategic Review Process Diffusion Board of Directors Rejects Woefully Inadequate, Unsolicited Offer for the Company by client of Investment Bank LifeSci Capital LifeSci-affiliated Fund Commences Proxy Contest for Control of the Diffusion Board Following Rejection of ...
ByCervoMed
Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to areas where it is needed most, will participate in the 2021 Alliance Global Partners Biotech & Specialty Pharma ...
ByCervoMed
Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that may enhance the body’s ability to deliver oxygen to areas where it is needed most, today announced that its Board of Directors (the “Board”) has authorized a thorough ...
ByCervoMed
Diffusion aligns with FDA on design of an open-label, dose-escalation, Phase 2 safety and efficacy study of trans sodium crocetinate (“TSC”) in newly diagnosed glioblastoma multiforme (“GBM”) patients Company to evaluate effects of TSC on tumor oxygenation using an innovative positron emission tomography (“PET”) hypoxia ...
ByCervoMed
(NASDAQ:DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing therapies that enhance the body’s ability to deliver oxygen to areas where it is needed most, today announced positive effects from its second Oxygenation Trial, the Altitude Trial. ...
ByCervoMed
Diffusion Pharmaceuticals Inc.(NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to areas where it is needed most, today announced that Robert Cobuzzi, Jr., Ph.D., the Company’s President and Chief Executive ...
ByCervoMed
Diffusion Pharmaceuticals Inc.(NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to areas where it is needed most, today announced a significant expansion of its Scientific Advisory Board (SAB) to include five ...
ByCervoMed
Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel therapies to deliver oxygen to areas of the body where it is needed most, today announced completion and topline data from the open-label, Phase 1b clinical trial of its novel, ...
ByCervoMed
Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to areas where it is needed most, announced today that the Company will present at H.C. ...
ByCervoMed
EO2 Concepts announced today the release of a new, larger wound dressing for post-surgical dehiscence and large, painful leg ulcers. This new 5x7 OxySpur oxygen diffusion dressing is part of the OxyGeni System which provides a complete oxygen therapy and wound monitoring system. Continuous Diffusion of Oxygen ...
Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (Diffusion or the Company), an innovative biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to areas where it is needed most, today announced that the Company has obtained clearance of its Investigational New Drug (IND) application submitted ...
ByCervoMed
AOTI Inc. announced today an eagerly anticipated expansion of its unique multi-modality Topical Wound Oxygen (TWO2) therapy product family. The addition of a new larger extremity-chamber to the company’s peripheral vascular disease (PVD) focused product line, allows for the application of TWO2 treatments for many more patients suffering from costly nonhealing chronic ...
The third oxygen atom easily bonds with many other types of molecules, thus altering their composition. With viruses such as the coronavirus, this free radical oxygen atom diffuses through the pathogen's protein coat and into the underlying nucleic acid, where it then damages the RNA the virus needs to replicate. ...
” A good aeration system can also offer a first line of defense against poor oxygen conditions and combat high surface temperatures. Using aeration to move water up from depth can increase oxygen and bring in colder water to fight the increased temperatures during the summer heat. ...
Fluence MABR uses passive aeration, the diffusion of oxygen through membranes. Packed in compact containerized systems, it provides efficient on-site treatment that meets the strictest discharge regulations. ...
Oxygen at atmospheric pressure diffuses through the membrane wall and feeds the aerobic digestion without bubbles. ...
Safety in the lab is of paramount importance to Peak, particularly when it comes to our gas generators. From the inital product development to the rigorous quality assurance all of our generators pass through before leaving our ISO:9001 accredited manufacturing facility, the safety features of our generators are put through their paces alongside the high performance standards we adhere to at ...
In conventional biological treatment, fine bubble aeration is used to deliver oxygen to the microorganisms that metabolize the nutrients and organic pollutants in the wastewater. However, this approach is not efficient since most of the oxygen is wasted. To make this process more efficient, GE’s technology team developed the ZeeLung technology, which ...